Related Experiment Video
Updated: Feb 12, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Endogenous Amplification of Apoptosis via p53 Regulation using a Cascade Nanocatalytic Medicine
Tan Wu1, Xiaoyue Xu1, Dan Xu2
1Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center For Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, China.
Abstract:
Nanocatalytic therapy is an emerging strategy that leverages in situ catalytic reactions within the tumor microenvironment to convert endogenous substrates into cytotoxic species, achieving spatially confined cancer cell killing with reduced systemic toxicity. However, the lack of durable, DNA-focused cytotoxic mechanisms hampers the translational efficacy of nanocatalytic therapy. Herein, we proposed a cascade nanocatalysis-mediated strategy for endogenous amplification of apoptosis, achieved by an engineered metal organic framework nanomedicine (MOF-Au-L-Arginine, abbreviated as MAL). The MOF serves both as a nanocatalyst and as a carrier for L-Arginine (L-Arg), while embedded Au nanoparticles enhance nanocatalyst reactivity. Subsequently, MOF catalyzes the generation of hydroxyl radicals (•OH) and superoxide anions (O2 •-), and then the O2 •- undergo a cascade reaction with NO released from L-Arg, generating highly cytotoxic peroxynitrite (ONOO-), which has greater cytotoxicity to tumor cells, can induce extensive DNA damage, and simultaneously impair DNA repair and disrupt the cell cycle. Genome-wide RNA sequencing reveals MAL can activate the p53 pathway, thereby regulating apoptosis related proteins. In addition, MAL reduces mitochondrial membrane potential and promotes mitochondrial-mediated apoptosis through the BAX/Bcl-2/caspase-3 axis, further amplifying endogenous apoptosis in tumor cells. In vivo, MAL effectively inhibits tumor growth with favorable biocompatibility.
Insights
This study introduces a novel nanocatalytic therapy using engineered metal-organic framework nanomedicine (MAL) to amplify cancer cell apoptosis. MAL effectively triggers DNA damage and cell cycle disruption, inhibiting tumor growth with good biocompatibility.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Nanocatalytic therapy offers localized cancer treatment by converting substrates into cytotoxic agents.
- Current limitations include a lack of durable, DNA-targeting cytotoxic mechanisms.
- Enhanced apoptosis induction is crucial for effective cancer cell killing.
Purpose of the Study:
- To develop a cascade nanocatalysis strategy for amplifying endogenous apoptosis in cancer cells.
- To engineer a metal-organic framework nanomedicine (MOF-Au-L-Arginine, MAL) for this purpose.
- To investigate MAL's mechanism of action and in vivo efficacy.
Main Methods:
- Fabrication of MOF-Au-L-Arginine nanomedicine (MAL).
- In vitro analysis of reactive oxygen species generation, DNA damage, cell cycle arrest, and apoptosis.
- Genome-wide RNA sequencing to identify pathway activation (e.g., p53).
- In vivo studies to evaluate tumor inhibition and biocompatibility.
Main Results:
- MAL effectively catalyzes the generation of hydroxyl radicals and superoxide anions, leading to peroxynitrite formation.
- Peroxynitrite induces significant DNA damage, impairs DNA repair, and disrupts the cell cycle.
- MAL activates the p53 pathway and promotes mitochondrial-mediated apoptosis via the BAX/Bcl-2/caspase-3 axis.
- In vivo studies demonstrated effective tumor growth inhibition with favorable biocompatibility.
Conclusions:
- The developed cascade nanocatalysis strategy effectively amplifies endogenous apoptosis for cancer therapy.
- MAL shows potential as a next-generation nanocatalytic therapeutic agent with enhanced efficacy and reduced toxicity.
- Further research into MAL's therapeutic applications is warranted.
Related Concept Videos
Negative Regulator Molecules
Intracellular Signaling Cascades
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Rab Cascades
Apoptosis
Amplifying Signals via Enzymatic Cascade

